U.S. Deep Brain Stimulation Devices Market Size & Outlook
U.S. deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
U.S. deep brain stimulation devices market highlights
- The U.S. deep brain stimulation devices market generated a revenue of USD 589.4 million in 2024 and is expected to reach USD 999.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 589.4 million |
| Market revenue in 2030 | USD 999.2 million |
| Growth rate | 9.3% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 42.0% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 150.9 million by 2030.
Dystonia was the largest segment with a revenue share of 68.73% in 2024. Horizon Databook has segmented the U.S. deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of major competitors & sophisticated healthcare infrastructure and supportive government initiatives are also responsible for market growth in the country. For instance, National Institute of Neurological Disorders and Stroke (NINDS) supports research activities on deep brain stimulation devices as an alternative treatment for PD.
Furthermore, increasing investments for conducting R&D on PD has helped raise awareness and boost development of new & innovative products and therapies for the treatment of this disease. For instance, the National Parkinson Foundation (NPF) provides funds to researchers and scientists with an aim to make advancements in this field.
Extensive research activities for inclusion and approval of deep brain stimulation devices in new application areas, such as depression and full-body MRI scans, are anticipated to boost the market growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. deep brain stimulation devices market size, by application, 2018-2030 (US$M)
U.S. Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
